A 56-year-old man with metastatic lung adenocarcinoma received combined 177 Lu-FAP-2286 radiation therapy and targeted therapy. After 1 treatment cycle, improvement of symptoms and radiological remission was observed. Moreover, the patient did not report any adverse effects.
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
sanvva
OK
Essence
lucky
小小牛马
vampv
nn
核桃
张欢馨
榴莲嘎嘎
yi
lizishu
行走的荷尔蒙
vc
土豆兵
Anonymous
初景
aajhajkahna
瘦瘦的书本
皖公网安备34019202002308
